Welcome To
Next Gen Bio Tech 2025:
Innovations in Genomics, Bioengineering, and Therapeutics
Join the global community of biotechnology innovators for a transformative event—Next Gen Bio Tech 2025, where science meets future potential. This one-day virtual gathering is designed to spotlight the latest breakthroughs in Genomics, Bioengineering, and Therapeutics, bringing together thought leaders, researchers, clinicians, policy-makers, investors, and students from around the world.

About the Webinar
Next Gen Bio Tech 2025 is a future-forward webinar showcasing the emerging technologies, visionary research, and real-world applications reshaping biotechnology. Our event aims to bridge the gap between academic excellence, industrial innovation, and public health outcomes.
Core Topics
Next-Gen Bioengineering & Synthetic Biology
Precision Genomics & CRISPR 3.0
AI-Powered Drug Discovery
Cellular & Gene Therapies
mRNA Technology & Beyond
Biotech Startups & Commercialization Pathways
Our Partners





- The global biotechnology market is projected to reach $3.88 trillion by 2030, growing at a CAGR of 13.9% from 2023 to 2030 (Source: Grand View Research).
- The genomics market alone is expected to surpass $94 billion by 2028, driven by advances in CRISPR, personalized medicine, and AI-powered data analysis.
- The bioengineering sector is seeing explosive growth, particularly in synthetic biology, which is expected to reach $45 billion by 2027.
- The therapeutics market, especially in gene and cell therapy, is projected to grow over 20% annually, with mRNA therapeutics expanding rapidly post-COVID.
- Investment in biotech startups reached over $60 billion globally in 2024, showing strong investor confidence in biotech’s transformative potential.